Jetema

216080 · KOSDAQ · Health Care · SMALL CAP

Revenue up 12.23% in FY2025.

Jetema reported consolidated results for FY2025: revenue of US$52.5M (+12.23% year on year), operating profit of US$2.61M (−7.1% year on year) and a net loss of US$5.08M.

Earnings(Change of 30% or more in revenue or profit/loss structure (15% for large companies))· FILED 2026-03-10· RCEPT 20260310901500

US$52.5MRevenue
+12.23%Revenue vs a year earlier
US$2.61MOperating profit

Converted at 1 USD ≈ ₩1,464.47 (filing-date rate, 2026-03-10 close)

What happened

Jetema reported consolidated results for FY2025: revenue of US$52.5M (+12.23% year on year), operating profit of US$2.61M (−7.1% year on year) and a net loss of US$5.08M.

Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.

RevenueUS$52.5M
Revenue vs a year earlier+12.23%
Operating profitUS$2.61M
Net income−US$5.08M
PeriodFY2025 (consolidated)
Filed2026-03-10, Change of 30% or more in revenue or profit/loss structure (15% for large companies)
SourceDART rcept 20260310901500 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-10 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.